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Complement receptor 3 (CR3) activation in microglia
is involved in neuroinflammation-related brain disor-
ders and pruning of neuronal synapses. Hypoxia,
often observed together with neuroinflammation
in brain trauma, stroke, and neurodegenerative dis-
eases, is thought to exacerbate inflammatory re-
sponses and synergistically enhance brain damage.
Here we show that when hypoxia and an inflamma-
tory stimulus (lipopolysaccharide [LPS]) are com-
bined, they act synergistically to trigger long-term
synaptic depression (LTD) that requires microglial
CR3, activation of nicotinamide adenine dinucleotide
phosphate oxidase (NADPH oxidase), and GluA2-
mediated A-amino-3-hydroxy-5-methyl-4-isoxazo-
lepropionic acid receptor (AMPAR) internalization.
Microglial CR3-triggered LTD is independent of
N-methyl-D-aspartate receptors (NMDARs), metab-
otropic glutamate receptors (mGluRs), or patterned
synaptic activity. This type of LTD may contribute
to memory impairments and synaptic disruptions in
neuroinflammation-related brain disorders.
INTRODUCTION
Microglia, the resident immune cells in the brain, are critically
involved in neuroinflammation in various pathological condi-
tions, including stroke, trauma, and neurodegenerative diseases
(Hanisch and Kettenmann, 2007; Kettenmann et al., 2011). In
the healthy brain, microglia exhibit highly motile processes that
frequently contact neuronal synapses (Wake et al., 2009) or sur-
round damaged tissue (Nimmerjahn et al., 2005). Recent studies
have shown that microglia shape neuronal networks by pruning
synapses during development (Kettenmann et al., 2013; Wake
et al., 2013) via activation of complement receptor 3 (CR3), a mi-
croglia-specific pattern recognition receptor consisting of a clus-
ter of differentiation molecule 11b (CD11b) and CD18 (Stephan
et al., 2012). Synaptic pruning probably requires the well-known
CR3 ligand complement 3 (Schafer et al., 2012; Stephan et al.,
2012; Stevens et al., 2007). However, in addition to complement
3, CR3 also directly recognizes various types of neuroinflamma-
tory stimuli such as lipopolysaccharide (LPS) (Flaherty et al.,1997; Wright and Jong, 1986), b amyloid (Zhang et al., 2011),
high-mobility group box 1 (HMGB1) (Gao et al., 2011),
a-synuclein (Zhang et al., 2007), and filamentous hemagglutinin
of bacteria (Relman et al., 1990), all of which can under some
circumstances cause neurotoxicity (Gao et al., 2011; Pei et al.,
2007; Zhang et al., 2007, 2011). Therefore, we have investigated
the impact of activating CR3 with an inflammatory ligand, LPS,
on synaptic function to provide insights into the pathology of
neuroinflammation-mediated brain disorders.
Inflammatory neuropathologies, such as stroke, trauma, and
neurodegenerative diseases, are often associated with hypoxia
from reductions and alterations in neurovascular coupling and
cerebral blood flow (Peers et al., 2009; Zlokovic, 2011). Hypoxia
can act synergistically with neuroinflammation to enhance dam-
age and precipitate cognitive decline in pathological conditions,
although the mechanisms by which hypoxia and inflammation
interact in the CNS are still largely unknown (Peers et al., 2009;
Zlokovic, 2011). Recent reports have shown that in the peripheral
immune system, inflammation and hypoxia share similar down-
stream pathways resulting in enhanced inflammatory reactions
(Nizet and Johnson, 2009; Rius et al., 2008). In this study, we
investigated whether hypoxia and an inflammatory stimulus
act synergistically to modulate synaptic function via a microglial
CR3-dependent mechanism.
RESULTS
LPS and Hypoxia Rapidly Induce Long-Term Synaptic
Depression in Both Rats and Mice with a Mechanism
that Requires Microglial CR3
In order to investigate the impact of concurrent CR3 activation
and hypoxia on synaptic transmission, we recorded field poten-
tials in the CA1 region of hippocampal brain slices from both rats
(wild-type [WT]) and mice (WT and CR3 knockout [CR3 KO]) and
applied combinations of LPS and a hypoxic stimulus (artificial
cerebrospinal fluid [aCSF] aerated with 8% O2). As shown in
Figure 1A, application of only LPS (10 mg/ml) on rat hippocampal
slices did not change basal synaptic transmission (n = 6,
101.2% ± 1.6% of baseline). Hypoxia alone (for 15 min) without
LPS caused awell-known transient depression of field excitatory
postsynaptic potentials (fEPSPs) from adenosine release (Dun-
widdie and Masino, 2001), which fully recovered after reperfu-
sion of normal aCSF (n = 6, 103.2% ± 7.5% of baseline 30 min
after normoxic reperfusion; Figure 1A). However, when we coap-
plied 15 min of 8% O2-aerated aCSF concurrently with LPS, weNeuron 82, 195–207, April 2, 2014 ª2014 Elsevier Inc. 195
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Figure 1. LPS and Hypoxia Induce LTD that Depends on Microglial CR3 Activation
Field recordings were performed in the CA1 area of hippocampal slices.
(A) Perfusion of LPS (10 mg/ml) did not alter basal synaptic transmission; hypoxia (8% O2-aerated aCSF) caused an immediate transient depression of fEPSP,
whichwas fully reversed after reperfusion of normoxic (95%O2 saturated) aCSF; when LPS and hypoxia were applied together, an LTD of fEPSPwas observed. In
all figures, sample traces were taken from the time points when statistics were performed.
(B) Western blot of CD11b in both WT and CR3 KO mice.
(C) Sample images of immunohistostaining of Iba-1 and DAPI staining of nuclei in stratum radiatum of hippocampal CA1 in both WT and CR3 KO mice.
(D) Microglial counts in both WT and CR3 KO mice. Microglia were recognized as Iba-1-positive cells with DAPI-positive nuclei in the middle.
(E) LPS and hypoxia induced LTD inWTmice but not in CR3 KOmice. Scale bars for all sample fEPSP traces in all figures represent 10ms (horizontal) and 0.5mV
(vertical). All error bars represent SEM.
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Microglial CR3 Triggers LTD via NADPH Oxidaseobserved long-term depression (LTD) of fEPSPs with a decrease
to 66.8% ± 3.7% of baseline (mean field potentials 30 min after
normoxic reperfusion, n = 5, p < 0.01 compared to hypoxia-196 Neuron 82, 195–207, April 2, 2014 ª2014 Elsevier Inc.only, Figure 1A). This depression, although not shown in the
figure, was observed to be stable at 64.3% ± 7.4% (n = 5) at
75 min after treatment. Our results show that concurrent hypoxia
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to subsequently as LPS+hypoxia LTD). Furthermore, as shown
in Figure S1 available online, increasing the concentration or
application time of any one of the stimuli (i.e., doubling concen-
tration of LPS [Figure S1A], 0% instead of 8%O2 [Figure S1B], or
doubling the duration of hypoxia exposure [Figure S1C]) did not
induce LTD in rat hippocampal slices, suggesting that the two
stimuli act synergistically to induce LTD.
In order to determine whether CR3 is the key receptor medi-
ating LPS+hypoxia LTD, we used CR3 KO mice (lacking subunit
CD11b) and WT mice. In the brain, CR3 is expressed exclusively
in microglia and CD11b is a well-established and selective
microglia marker (Hickman et al., 2013). We confirmed that
CD11b and ionized calcium binding adaptor molecule 1 (Iba-1)
staining overlapped on the same cells in WT mice (Figure S2A).
In hippocampal tissue from CR3 KOmice, CD11b was undetect-
able by western blots (Figure 1B), and we could see no immuno-
histochemical staining for CD11b in Iba-1-positive microglia
(Figure S2B). In addition, we observed no striking differences
in morphology of Iba-1-positive microglial in the hippocampus
(CA1 stratum radiatum) fromCR3KO compared toWTmice (Fig-
ure 1C). Furthermore, Figure 1D shows that microglial number
counts in the CA1 stratum radiatum from WT and CR3 KO are
not significantly different (14.2 ± 0.8/field in WT and 14.3 ± 1.1/
field in CR3 KO, p > 0.05, 18 fields from 3 animals in each group).
One field was defined as a stack of 23 images (separated by
1 mm) with dimensions of 212 mm3 212 mm and a total thickness
of 22 mm.
In slices obtained from WT mice, LPS (15 mg/ml) applied
concurrently with 8% O2-aerated aCSF for 25 min induced an
LTD with a decrease to 65.2% ± 4.6% of baseline (calculated
based on mean field potentials 75 min after normoxic reperfu-
sion, n = 6; Figure 1E). However, when we applied the same
treatment on slices obtained from CR3 KO mice, LTD was not
observed and field potentials recovered to 99.7% ± 4.6% of
baseline (n = 9, p < 0.001 compared to WT mice; Figure 1E).
The absence of LTD in CR3 KOmice indicates that LPS and hyp-
oxia induced LTD with a mechanism that requires activation of
microglial CR3.
LPS+Hypoxia LTD Is Not Dependent on NMDAR, mGluR,
Adenosine Deceptor, or Toll-like Receptor 4
Wenext explored the pathways downstreamof CR3 activation to
investigate whether LPS+hypoxia LTD was similar to previously
reported types of LTD that require activation of N-methyl-
D-aspartate receptors (NMDARs) or metabotropic glutamate
receptors (mGluRs) (Collingridge et al., 2010) or adenosine A1 re-
ceptors that are activated by adenosine release during hypoxia
(von Lubitz, 1999). As shown in Figures 2A and 2B, antagonists
of these receptors had no effect on LPS+hypoxia LTD in rat hip-
pocampal slices (60.2% ± 5.3% of baseline in the NMDAR
antagonist APV [100 mM], n = 6, p > 0.05; 68.4% ± 5.7% of base-
line in the group I/II mGluR antagonist [(R,S)-a-methyl-4-carbox-
yphenylglycine (MCPG, 250 mM)], n = 6, p > 0.05; 73.4% ± 3.2%
of baseline in the selective group II mGluR blocker LY341495
[100 mM], n = 5, p > 0.05; 63.4% ± 3.8% of baseline in the aden-
osine A1 receptor blocker 8-cyclopentyl-1,3-dipropylxanthine
[DPCPX, 500 nM], n = 6, p > 0.05). These results suggest thatLPS+hypoxia LTD is not mediated by NMDAR, mGluR, or A1
receptor activation.
Previous studies have shown that LPS activatesmicroglial toll-
like receptor 4 (TLR4) and subsequently blocks the induction of
LTP by triggering the release of cytokines in a complex process
involving transcription, translation, and synthesis of cytokines
(Hauss-Wegrzyniak et al., 2002; Kettenmann et al., 2011; Nolan
et al., 2004). To examine the possible participation of the TLR4
pathway, we applied TAT-MyD88 (YGRKKRRQRRR-RDVLPGT),
a peptide that blocks the interaction between TLR4 and its
adaptor MyD88, therefore inhibiting part of the downstream
signaling pathway that produces cytokines (Hines et al., 2013).
As shown in Figure 2C, when included in the preincubation (for
1 hr) and perfusion solutions, TAT-MyD88 (1 mM) did not block
LPS+hypoxia LTD in rat hippocampal slices, leading to a depres-
sion 75.8% ± 2.8% of baseline (n = 4, p > 0.05 compared to
LPS+hypoxia, p < 0.01 compared to hypoxia alone). Therefore,
our results suggest that the TLR4-induced MyD88-dependent
pathway is not essential in LPS+hypoxia LTD.
To further investigate the role of TLR4 activation in LPS+
hypoxia LTD, we tested LPS+hypoxia LTD in slices obtained
from TLR4 KO mice. LPS (15 mg/ml) applied concurrently with
8%O2-aerated aCSF for 25 min induced an LTD with a decrease
to 65.9% ± 9.3% of baseline 75 min after normoxic reperfusion
(n = 7, p > 0.05 compared to WT mice, and p < 0.001 compared
to CR3 KO mice; Figure 2D). Taken together, our observations
suggest that TLR4 activation does not play a major role in LPS+
hypoxia LTD.
LPS+Hypoxia LTD Requires Activation of NADPH
Oxidase
Previous studies have reported that the stimulation of microglial
CR3 by LPS rapidly activates nicotinamide adenine dinucleotide
phosphate oxidase (NADPH oxidase), which produces superox-
ide that reaches peak levels within 30 min (Pei et al., 2007; Qin
et al., 2004). NADPH oxidase, known to play a key role in neuro-
degeneration (Gao et al., 2012), can be activated by neuroinflam-
mation and hypoxia through distinct pathways (Bedard and
Krause, 2007). Therefore, we investigated the possible contri-
bution of NADPH oxidase to LPS+hypoxia LTD. The NADPH
oxidase blocker apocynin (100 mM) completely prevented
LPS+hypoxia LTD in rat hippocampal slices when coapplied
(97.2% ± 4.3% of baseline, n = 5, p < 0.01 compared to
LPS+hypoxia, and p > 0.05 compared to hypoxia alone; Fig-
ure 3A). When we applied apocynin 15 min after reperfusion
of normoxic solution, LPS+hypoxia LTD was still observed
(67.8% ± 9.2%, n = 4, p > 0.05 compared to LPS+hypoxia; Fig-
ure 3A), indicating that NADPH oxidase is required for the induc-
tion, but not themaintenance, of LPS+hypoxia LTD. Furthermore,
we also applied apocynin onto hippocampal slices of WT
mice. As shown in Figure 3B, apocynin completely blocked the
LPS+hypoxia-induced LTD, leading to a recovery 95.8% ±
1.4% of baseline (n = 5, p < 0.001 compared to LPS+hypoxia in
WT mice, p > 0.05 compared to LPS+hypoxia in CR3 KO mice).
To further confirm the involvement of NADPH oxidase, we
tested a widely used NADPH oxidase-blocking peptide TAT-
Phox (RKKRRQRRR-CSTRIRRQL) (Rey et al., 2001) and found
that when included in the preincubation (for 1 hr) and perfusionNeuron 82, 195–207, April 2, 2014 ª2014 Elsevier Inc. 197
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Figure 2. LPS+Hypoxia LTD Is Independent on NMDAR, mGluR, and TLR4
(A) APV (100 mM) or DPCPX (500 nM) was bath applied at least 20 min before the application of LPS+hypoxia and was included in all solutions throughout the
experiment. Neither blocker significantly altered the LPS+hypoxia LTD. In (A)–(C), the dashed gray line indicates the hypoxia-only experiment in Figure 1A, while
the solid blue line indicates hypoxia+LPS in Figure 1A.
(B) MCPG (250 mM) or LY341495 (100 mM) was applied the same way as blockers in (A). Neither blocker altered LPS+hypoxia LTD.
(C) TAT-MyD88 (1 mM) did not affect LPS+hypoxia LTD.
(D) LPS+hypoxia induced LTD in TLR4 KOmice. The dashed gray line indicates the LPS+hypoxia experiment in CR3KOmice (from Figure 1E), while the solid blue
line indicates hypoxia+LPS in WT mice (from Figure 1E). All error bars represent SEM.
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pocampal slices (95.5% ± 1.1% of baseline 40 min after reperfu-
sion, n = 6, p < 0.01 compared to LPS+hypoxia, and p > 0.05
compared to hypoxia alone; Figure 3C). The control scrambled
peptide TAT-Phoxscr (RKKRRQRRR-CLRITRQSR) (1 mM) did
not alter the level of LPS+hypoxia LTD (67.1% ± 10.5% of
baseline, n = 4, p > 0.05 compared to LPS+hypoxia LTD without
peptide; Figure 3C).
The pharmacological sensitivity of LPS+hypoxia LTD indicates
that this is a form of LTD mediated by microglia activation and
NADPH oxidase. Previous studies have shown that lower O2
levels in some tissues enhance NADPH oxidase activity because
increased glycolysis raises lactate/pyruvate ratios and thereby
NADPH/NADP+ ratios, which accelerate the production of su-
peroxide from NADPH oxidase (Raddatz et al., 2011; Yang and
Kahn, 2006). We postulated that lactic acid could be a contrib-
uting factor when released during hypoxia. Therefore, we tested
whether lactic acid (3 mM) could mimic the actions of hypoxia to
act synergistically with LPS to trigger LTD. We applied lactic
acid, which decreased the pH of aCSF from 7.35 ± 0.01 to
7.01 ± 0.01 (n = 12). When the rat hippocampal slices were
exposed to lactic acid alone for 30 min, basal transmission
was not changed, remaining at 100.2% ± 1.2% of the baseline198 Neuron 82, 195–207, April 2, 2014 ª2014 Elsevier Inc.(n = 6; Figures 3D and 3E). However, when LPS was applied
together with lactic acid, we observed a depression of synaptic
transmission (79.5% ± 5.1% of baseline, n = 6, p < 0.01
compared to lactic acid only), which was completely blocked
by apocynin (101.7% ± 4.9% of baseline, n = 6, p < 0.01
compared to LPS+lactic acid, and p > 0.05 compared to lactic
acid only; Figures 3D and 3E). Statistics were based on fEPSPs
10 min after treatment when the depression was fully developed
and stable. These data suggest that when NADPH oxidase is
activated by an inflammatory stimulus (LPS in this experiment),
lactic acid further enhances the activity of this enzyme to a
degree that is sufficient to induce LTD.
Reactive Oxygen Species Produced by NADPH Oxidase
Play a Key Role in the Induction of LPS+Hypoxia LTD
NADPH oxidase produces superoxide, a member of the reactive
oxygen species (ROS) family, which generates other ROS such
as hydrogen peroxide and peroxynitrite (Bedard and Krause,
2007). Increased ROS generation can potentially modulate syn-
aptic transmission and is widely considered as a leading cause
of neuronal dysfunction in neurodegenerative disorders (Gao
et al., 2012; Reynolds et al., 2007). To test the role of ROS release
in the induction of this form of LTD, we used ascorbic acid
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Figure 3. LPS+Hypoxia LTD Depends on Activation of NADPH Oxidase
(A) Apocynin (100 mM) was bath applied either at least 30 min before or 30 min after the application of LPS and hypoxia. Early application reversed LPS+hypoxia
LTD, while late application did not have an effect. In (A) and (C), the dashed gray line indicates the hypoxia-only experiment (from Figure 1A), while the solid blue
line indicates hypoxia+LPS (from Figure 1A).
(B) In slices of WT mice, apocynin was bath applied at least 30 min before and during treatment. The application of apocynin blocked the LPS+hypoxia LTD. The
dashed gray line indicates the LPS+hypoxia experiment in CR3 KO mice (Figure 1E), while the solid blue line indicates hypoxia+LPS in WT mice (Figure 1E).
(C) NADPH oxidase-blocking peptide TAT-Phox (1 mM) inhibited LPS+hypoxia LTD, while scrambled peptide (TAT-Phoxscr, 1 mM) did not.
(D) Thirty minute application of lactic acid and LPS depressed basal transmission, while lactic acid alone did not alter it. Apocynin completely blocked this
LPS+lactic acid-induced depression.
(E) Statistics of (D).
(F) Summary statistics of Figures 1A, 2A–2C, 3A, 3C, 4A, and 5B, and 5C. Statistics were based on fEPSPs 30 min after reperfusion except TAT-Phox and
TAT-Scr, which were analyzed based on fEPSPs 40 min after reperfusion.
(G) Summary statistics of mice experiments, including Figures 1E, 2D, and 3B. Statistics were based on fEPSPs 75min after reperfusion due to a slower recovery.
All error bars represent SEM.
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Figure 4. NADPH Oxidase-Produced Superoxide Plays a Key Role in the Induction of LPS+Hypoxia LTD
(A) Application of ascorbic acid (400 mM) blocked LPS+hypoxia LTD. The dashed gray line indicates the hypoxia-only experiment (from Figure 1A) while the solid
blue line indicates hypoxia+LPS (from Figure 1A).
(B and C) LPS and hypoxia together caused a gradual increase of ROS fluorescent signal in the CA1 region but did not change fluorescence when applied
separately (B). Apocynin blocked the LPS+hypoxia-induced ROS increase (statistics shown in C).
(D) LPS+hypoxia increased lipid peroxidation levels in slices, while separate applications had no effect. Apocynin completely blocked this increase. All error bars
represent SEM.
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Microglial CR3 Triggers LTD via NADPH Oxidase(400 mM), a ROS scavenger, in the preincubation solution (for
1 hr) and recording solution. As shown in Figure 4A, ascorbic
acid completely blocked LPS+hypoxia LTD in rat hippocampal200 Neuron 82, 195–207, April 2, 2014 ª2014 Elsevier Inc.slices (102.4% ± 5.9% of baseline, n = 6, p < 0.01 compared
to LPS+hypoxia, and p > 0.05 compared to hypoxia alone).
This result, combined with the data using NADPH oxidase
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Microglial CR3 Triggers LTD via NADPH Oxidaseinhibitors (Figures 3A and 3B), suggests that LPS+hypoxia LTD is
induced by ROS release through activation of NADPH oxidase.
To provide two independent indications that LPS and hypoxia
synergistically induced ROS generation in rat hippocampal sli-
ces, first we detected ROS changes by two-photon imaging of
a ROS-sensitive dye 5-(and-6)-carboxy-20,7’-dichlorodihydro-
fluorescein diacetate (Carboxy-H2DCFDA) (Fekete et al., 2008)
and, second, we measured lipid peroxidation levels in treated
brain slices. The nonfluorescent carboxy-H2DCFDA is converted
to a green fluorescent form when it is oxidized by the activity of
ROS, and the generation of ROS is indicated by the progressive
accumulation of green fluorescence within cells (Halliwell and
Whiteman, 2004). As shown in Figures 4B and 4C, the fluores-
cence in the stratum radiatum layer of CA1 did not significantly
increase when slices were exposed to either hypoxia or LPS
separately, although there was a nonsignificant upward trend
possibly due to tissue illumination (hypoxia: 103.3% ± 1.1% of
baseline, n = 6, p > 0.05 compared to a preapplication control
period; LPS: 102.6% ± 1.4% of baseline, n = 6, p > 0.05
compared to a preapplication control period). However, when
both hypoxia and LPS were present, the average fluorescence
intensity steadily increased to 109.6% ± 1.4% of baseline (n =
6, p < 0.01 compared to baseline) at 30 min after reperfusion
of normoxic solution, indicating a significant increase in ROS
levels upon LPS+hypoxia treatment. This increase of ROS fluo-
rescent signal was completely blocked by the NADPH oxidase
inhibitor apocynin (102.5% ± 1.3% of baseline, n = 6; Figures
4B and 4C; p > 0.05 compared to baseline).
We further confirmed that LPS and hypoxia cause oxidative
stress in slices bymeasuring lipid peroxidation levels 30min after
reperfusion in slices treated identically as in the electrophysi-
ology experiments. As shown in Figure 4D, LPS and hypoxia
together increased lipid peroxidation to 120.8% ± 5.9% of con-
trol level (n = 9, p < 0.01 compared to control), whereas when
applied separately, neither LPS nor hypoxia increased lipid per-
oxidation level (102.7% ± 3.6% and 103.1% ± 4.3% of control
respectively, n = 6 each, p > 0.05 compared to control). Apocynin
treatment nonsignificantly decreased the baseline (87.4% ±
5.8% of control, n = 5, p > 0.05 compared to control) and
completely blocked the LPS-hypoxia-induced increase of lipid
peroxidation in slices (combination of LPS, hypoxia, and apocy-
nin was 84.2% ± 4.7% of control, n = 6, p > 0.05 compared to
apocynin alone, and p < 0.001 compared to LPS+hypoxia
without apocynin). Therefore, both imaging Carboxy-H2DCFDA
fluorescence and measuring lipid peroxidation indicated that
ROS generation is significantly increased in brain slices when
both LPS and hypoxia are applied together but not separately.
To test whether lipid peroxidation leads to acute cell damage
during the time course of these experiments, we measured
lactate dehydrogenase (LDH) release as an indicator of acute
cell death. As shown in Figure S3A, LPS+hypoxia did not in-
crease LDH release from rat hippocampal slices up to 3 hr after
treatment. In addition, intracellular calcium ([Ca2+]i) in hippocam-
pal neurons did not change significantly and there was no
apparent loss of dye, which might occur if cells were damaged
(Figures S3B–S3D). Furthermore, cells in slices showed no
shrinkage or swelling throughout the whole experiment, indi-
cating that the slices were still in a relatively healthy state.PP2AActivation Plays an Important Role in LPS+Hypoxia
LTD
After confirming the production of superoxide from NADPH oxi-
dase after microglial CR3 activation, we further explored the
mechanism in neurons that leads to LTD. Protein phosphatase
2A (PP2A) has been shown to play a key role in the induction
and maintenance of LTD (Mulkey et al., 1993; Nicholls et al.,
2008). Furthermore, previous studies have shown that superox-
ide and its product hydrogen peroxide can increase PP2A activ-
ity (Caraballo et al., 2011; Maalouf and Rho, 2008; Sheth et al.,
2009). Therefore, we postulated that ROS-dependent activation
of PP2A could contribute to LPS+hypoxia LTD.
To test this possibility, wemeasured PP2A activity in rat hippo-
campal slices 30 min after reperfusion of normoxic solution
and found that PP2A activity was significantly increased by
LPS+hypoxia treatment (143.6% ± 6.2% of control level, n = 6,
p < 0.001 compared to control group) versus significantly smaller
changes in LPS alone (119.9% ± 4.3%, n = 6, p < 0.05 compared
to LPS+hypoxia) or hypoxia alone (118.5% ± 6.6%, n = 6, p <
0.01 compared to LPS+hypoxia) (Figure 5A).
Furthermore, we applied okadaic acid (250 nM), a PP2A
blocker, in preincubation solution (for 1 hr) and found that
LPS+hypoxia LTD was blocked (91.4% ± 4.0% of baseline, n =
5, p < 0.05 compared to LPS+hypoxia, and p > 0.05 compared
to hypoxia alone; Figure 5B). Taken together, our results indicate
an important role of PP2A activation in the induction of
LPS+hypoxia LTD.
LPS+Hypoxia LTD Is Induced by GluA2-Mediated
AMPAR Endocytosis
A-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid recep-
tor (AMPAR) endocytosis is a well-knownmechanism underlying
NMDAR-dependent LTD in CA1 pyramidal neurons (Beattie
et al., 2000). It has been shown that AMPAR endocytosis is
dependent on the GluA2 subunit and this process can be
blocked by a peptide (GluA23Y) that mimics the end of the
GluA2 C terminus (Ahmadian et al., 2004).
We examined whether LPS+hypoxia LTD was mediated
by GluA2-dependent AMPAR endocytosis, by testing the sensi-
tivity to the GluA23Y-interfering peptide. Using extracellular field
potential recordings, we found that when 1 mM TAT-GluA23Y
(YGRKKRRQRRR-YKEGYNVYG) was included in the prein-
cubation (for 1 hr) and perfusion solutions, the induction of
LPS+hypoxia LTD was blocked in rat hippocampal slices
(fEPSPs were 92.2% ± 3.9% of baseline, n = 6, p < 0.01
compared to LPS+hypoxia, and p > 0.05 compared to hypoxia
alone; Figure 5C), suggesting a key role of AMPAR endocytosis
in LPS+hypoxia LTD.
We next investigated whether the release of superoxide
from exogenous sources within brain slices would generate
LTD that is similar to LPS+hypoxia LTD and whether this LTD
would be sensitive to TAT-GluA23Y. To address this question,
we used xanthine/xanthine oxidase (X/XO), a widely used super-
oxide-generating system (Knapp and Klann, 2002), to see
whether this would mimic the effect of LPS+hypoxia. As shown
in Figures 5D and 5E, we applied X/XO (20 mg/ml/25 mg/ml)
onto the slices for 20 min and observed a transient depression
of synaptic transmission. After reperfusion with normal aCSF,Neuron 82, 195–207, April 2, 2014 ª2014 Elsevier Inc. 201
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Figure 5. LPS+Hypoxia LTD Is Induced by PP2A Activation and GluA2-Mediated AMPAR Endocytosis
(A) PP2A activity assay showed that PP2A activity was significantly increased by LPS+hypoxia treatment versus significantly smaller increases in LPS or hypoxia
alone.
(B) Slices were preincubated in okadaic acid (250 nM) for 1 hr before experiments. Okadaic acid blocked the induction of LPS+hypoxia LTD. In (B) and (C), the
dashed gray line indicates the hypoxia-only experiment (from Figure 1A), while the solid blue line indicates hypoxia+LPS (from Figure 1A).
(C) TAT-GluA23Y (1 mM) blocked the induction of LPS+hypoxia LTD.
(D) Twenty minute perfusion of X (20 mg/ml)/XO (25 mg/ml) induced an LTD, which was blocked by TAT-GluA23Y (1 mM, 1 hr preincubation and present all through
the experiments).
(E) Statistics of (D) 60 min after treatment. All error bars represent SEM.
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Figure 6. LPS+Hypoxia LTD Is Mediated by Postsynaptic Mechanism Involving GluA2-Mediated AMPAR Endocytosis
(A) LPS and hypoxia caused a decrease of mEPSC amplitude in CA1 neurons. This amplitude decrease was blocked by GluA23Y peptide but not by a scrambled
control GluA2scr (both peptides applied at 50 mg/ml in internal solution).
(B) Measurement of mEPSC frequency shows no significant difference between baseline and 30 min after reperfusion.
(C) Sample average traces of (A). Scale bars represent 5 ms (horizontal) and 5 pA (vertical).
(D–F) Cumulative fractions of mEPSC amplitude before and after LPS+hypoxia treatment in control (D), in GluA23Y (E), and in GluA2scr (F). All error bars
represent SEM.
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2.2%of baseline 60min after treatment, n = 5), further confirming
an important role of ROS in the induction of LPS+hypoxia LTD.
When included in preincubation (1 hr) and perfusion solutions,
TAT-GluA23Y (1 mM) blocked X/XO-induced LTD, resulting in a
full recovery 60min after X/XO treatment (97.1%± 5.4%of base-
line, n = 5, p < 0.01 compared to X/XO; Figures 5D and 5E).
To further investigate the role for AMPAR internalization
in LPS+hypoxia LTD,we performedwhole-cell voltage-clamp re-
cordings ofminiature excitatory postsynaptic currents (mEPSCs)
in CA1 pyramidal neurons with GluA23Y (YKEGYNVYG) or the
scrambled peptide GluA2scr (AKEGANVAG) in the recording
pipette. After obtaining a stable baseline (10 min), we applied
hypoxic aCSF (8% O2 saturated) with LPS (10 mg/ml) for
15 min, followed by reperfusion of normoxic aCSF containing
LPS. As shown in Figures 6A, 6C, and 6D, the treatment of LPS
and hypoxia resulted in a decrease of mEPSC amplitude(65.1%±4.2%of baseline, n =4, p<0.001 compared to baseline)
20–25 min after reperfusion. When GluA23Y (50 mg/ml) was
included in the recording pipette, LPS+hypoxia LTDwas blocked
(mEPSC amplitude 97.4% ± 3.7% of baseline, n = 5, p < 0.001
compared to LPS+hypoxia; Figures 6A, 6C, and 6E), while inclu-
sion of GluA2scr did not change the level of LPS+hypoxia
LTD (73.8% ± 1.7% of baseline, n = 4, p > 0.05 compared to
LPS+hypoxia; Figures 6A and 6F). As shown in Figure 6B, the
treatments did not change mEPSC frequency. Taken together,
our results indicate a key role for AMPAR endocytosis in the
expression of LPS+hypoxia LTD.
As AMPAR endocytosis has been known to play an important
role in LTD that is induced by other stimuli (Beattie et al., 2000;
Collingridge et al., 2010), we further tested whether the LPS+
hypoxia LTD that we observed would occlude subsequent LTD
triggered by othermethods. As shown in Figure S4, LPS+hypoxia
LTD did not occlude low-frequency stimulation (LFS)-inducedNeuron 82, 195–207, April 2, 2014 ª2014 Elsevier Inc. 203
Figure 7. Summary Figure
Inflammatory stimulus LPS and hypoxia synergisti-
cally activate NADPH oxidase in a CR3-dependent
manner. NADPH oxidase produces superoxide,
which then activates PP2A and induces LTD via
AMPAR internalization in postsynaptic terminals.
Neuron
Microglial CR3 Triggers LTD via NADPH OxidaseLTD (NMDAR dependent) or dihydroxyphenylglycine (DHPG)-
induced LTD (mGluR dependent).
DISCUSSION
Our results indicate that stimulation of microglial CR3 can trigger
LTD in surrounding neurons. The experiments using the A1 re-
ceptor antagonist (Figure 2A) revealed that this surprising
communication betweenmicroglia and neurons can occur within
15 min after applying the inflammatory stimulus LPS in combina-
tion with transient hypoxia. Although LPS also acts through other
receptor systems such as TLR4 in addition to CR3 (Kettenmann
et al., 2011), our results showing the inability of LPS and hypoxia
to elicit LTD in the CR3 KO mice demonstrate a critical role of
microglial CR3 in regulating synaptic plasticity. TLR4 does not
appear to be an essential receptor in this process as LPS+
hypoxia LTD was still observed in TLR4 KO mice, and a peptide
that disrupts TLR4-MyD88 interactions and LPS-triggered cyto-
kine formation (Hines et al., 2013) did not impair LPS+hypoxia
LTD. Microglial CR3-triggered LTD results from NADPH oxidase
activation and is independent of NMDAR or mGluR stimulation
or a specific pattern of synaptic activation. The production of
superoxide from NADPH oxidase induces LTD via activation of
PP2A and GluA2-mediated AMPAR internalization (Figure 7).
Our study identifies a form of relatively rapid microglia-neuronal
communication through which an enhanced neuroinflammatory
response in microglia directly modulates synaptic transmission.
These results provide a paradigm by which microglial NADPH
oxidase can modify neuronal activity and synaptic function.
CR3 has recently been shown to have important roles in the
physical removal of synapses during development in a process
called synaptic pruning (Schafer et al., 2012; Stephan et al.,
2012; Stevens et al., 2007). Our findings indicate that there is
also a role formicroglial CR3 inmodifying the dynamic properties
of active synapses by triggering a reduction in synaptic efficacy.204 Neuron 82, 195–207, April 2, 2014 ª2014 Elsevier Inc.Given a known correlation between spine
structure and synaptic strength (Kasai
et al., 2010), the link between CR3 activa-
tion and synaptic depression could be
relevant to the microglia-induced syn-
aptic pruning. The depression of synaptic
efficacy could be a prelude to the direct
involvement of microglia in synaptic
pruning, which has a longer time of onset
than LTD.
The activation of PP2A has been recog-
nized as a key step in induction of stim-
ulus-dependent and chemical-dependent
LTD (Mulkey et al., 1993; Nicholls et al.,2008), and there are several possible mechanisms leading
from LTD-inducing synaptic activation to PP2A activation (Pi
and Lisman, 2008). Although the LPS+hypoxia LTD that we
describe here occurs independently of synaptic activation, we
explored the potential involvement of PP2A as studies in both
neurons and other cell types have demonstrated a link between
ROS generation and PP2A activation (Caraballo et al., 2011;
Maalouf and Rho, 2008; Sheth et al., 2009). We found that
LPS+hypoxia induction of LTD was associated with the activa-
tion of PP2A and was blocked by okadaic acid, an inhibitor of
PP2A, suggesting that the ROS generation by NADPH oxidase
in microglia could cause PP2A activation in neurons leading to
AMPAR internalization.
NADPH oxidase has been shown to be a key enzyme that me-
diates neurotoxicity in trauma, stroke, and various neurodegen-
erative disorders including Alzheimer’s disease and Parkinson’s
disease (Block et al., 2007; Gao et al., 2012). Oxidative stress has
been implicated in numerous studies of neurodegeneration, and
variousmethods to attenuate oxidative stress have shown prom-
ising results in clinical studies (Barnham et al., 2004), suggesting
that targeting the source of the oxidative stress signals such as
NADPH oxidase may be useful in alleviating some of the deteri-
oration in neurodegeneration (Drummond et al., 2011; Gao et al.,
2012). The activation of NADPH oxidase, shown by our study
to reduce synaptic efficiency, may contribute to the memory
impairments and synaptic disruptions that are characteristics
of dementias and may be a therapeutic target to alleviate mem-
ory loss in these brain disorders.
Decreased cerebral blood flow (CBF) (possibly triggered
by ministroke infarcts or impaired neurovascular coupling) is
considered to be a major contributing factor to cognitive impair-
ment and is recognized as an important risk factor for dementia
(Zlokovic, 2011). Hypoxia associated with reduced CBF can
enhance damage caused by neuroinflammation (Peers et al.,
2009; Zlokovic, 2011). Containment of neuroinflammation is
Neuron
Microglial CR3 Triggers LTD via NADPH Oxidaseimportant for reducing cognitive decline and it has been
suggested that unrestrained neuroinflammation may lead to
increased predisposition to Alzheimer’s disease (Jonsson
et al., 2013). Our finding that hypoxia enhances the impact of
LPS on synaptic function suggests the importance of preventing
CNS hypoxia for restraining the effects of neuroinflammation
in vivo. Further studies on the impact of microglial CR3-mediated
LTD will be important in determining the degree to which it con-
tributes to the memory impairments and synaptic disruptions
that are characteristics of dementias and whether it could be
a therapeutic target to alleviate memory loss before there is
cell loss.
EXPERIMENTAL PROCEDURES
Animals
Sprague-Dawley rats (postnatal days 18 to 23) were used in most of the exper-
iments unless otherwise indicated. CR3 KO mice (1–3 months old), TLR4 KO
mice (1–3 months old), and WT controls (1–3 months old) were purchased
from Jax Mice.
Hippocampal Slice Preparation
Animals were anesthetized and decapitated according to protocols approved
by the University of British Columbia committee on animal care. Transverse
hippocampal slices were prepared in ice-cold slicing solution followed by
1 hr recovery at room temperature.
Field Recording
Field recordings were performed in the Schaffer collateral pathway in CA1 re-
gion at room temperature (22C–25C). fEPSP signals were amplified with an
AC amplifier (Molecular Devices), digitized using a Digidata 1440A interface
board (Axon Instruments), and transferred to a computer with Clampex 10.0
(Molecular Devices). fEPSPs were quantified by initial slope, which in further
analysis was normalized to the mean of baseline. The mean normalized fEPSP
slope was plotted as a function of timewith every dot representing the average
of four sweeps (2 min) and error bars representing SEM. Statistics were based
on mean values of eight sweeps within 4 min around the chosen time point.
In the experiments on brain slices from rats, LTD was induced by hypoxic
stimulus (8% O2, 5% CO2, 87% N2 saturated aCSF for 15 min) with
10 mg/ml LPS and data were included when recordings were stable by
40 min after reperfusion. LTD was induced by hypoxic stimulus (8% O2-satu-
rated aCSF for 25 min) with 15 mg/ml LPS in the experiments on brain slices
frommice and data were includedwhen recordings were stable by 75min after
reperfusion. It required higher LPS concentration and longer hypoxia exposure
to trigger LTD in mice (1–3 months old) than in rats (18–23 days). This change
may be due to differences in the sensitivity to LPS and/or hypoxia between
mice and rats at these different ages.
Field recording experiments were not performed in a blinded manner. The
experiments in mice were performed in a randomized manner, while experi-
ments in rats were not.
Whole-Cell Recording
Whole-cell recordings were performed at room temperature on CA1 pyramidal
neurons that were voltage clamped at70 mV. mEPSC signals were amplified
using a Multiclamp 700B amplifier (Axon Instruments), digitized using a 1440A
digidata, and recorded with Clampex 10.0. Data were analyzed using
MiniAnalysis (Synaptosoft).
Two-Photon Imaging
ROS were monitored by Carboxyl-H2DCFDA, while [Ca
2+]i was indicated
by Rhod-2 AM. We successfully stained neurons with Rhod-2 (in contrast
to the typical astrocyte staining) when we used a previously published pro-
tocol that was demonstrated to facilitate loading of –AM dyes into neurons
in brain slices (Trevelyan et al., 2006) and included cremophor in the staining
procedure as described in the Supplemental Experimental Procedures.Imaging was performed with a two-photon laser-scanning microscope
(Zeiss LSM510-Axioskop-2) directly coupled to a Mira Ti:sapphire laser
(100 fs pulses, 76 MHz, Coherent). Images were obtained at 40–50 mm
below the surface and were analyzed after experiments using ImageJ. Fluo-
rescent signals were quantified as Ft/F0, where Ft and F0 represent fluores-
cence signal at a given time during treatments and that of the baseline,
respectively.
Lipid Peroxidation Assay
Lipid peroxidation assay kit (Biomedical Research Service Center, State
University of NewYork at Buffalo) was used to assess oxidative stress in slices.
Results were normalized by total protein levels of the samples.
LDH Assay
Extracellular LDH was measured using LDH assay kits (State University of
New York at Buffalo). aCSF with 5% Triton X-100, a detergent to break cell
membranes, was used as the positive control. Cell death was calculated as
percentage of superfusate LDH compared to the sum of superfusate LDH
and brain slice LDH.
Western Blotting
The brain slices were homogenized using lysis buffer. The homogenates were
then centrifuged at 13,0003 g (20 min, 4C) and prepared as samples accord-
ing to protein concentrations. After SDS/PAGE, proteins were transferred
to PVDF membranes. Mouse anti-CD11b monoclonal antibody (Abcam,
1:500 [2 mg/ml]) and anti-mouse secondary antibody (1:2,000) conjugated to
horseradish peroxidase were used. Bands were visualized using enhanced
chemiluminescence (ECL; Amersham Bioscience).
Immunohistochemistry
For Figure 1C and Figure S2A, wild-type and CD11b knockout mice were
perfused intracardially with paraformaldehyde (PFA). Brains were postfixed
in PFA and cryosectioned (40 mm) as free-floating coronal slices. Sections
were incubatedwith blocking solution, followed by primary antibodies directed
against Iba-1 (1:1,000 [0.5 mg/ml]; Wako) and CD11b (1:500 [2 mg/ml];
AbD Serotec) and secondary antibodies (Alexa-Fluor-488-conjugated goat
anti-rabbit IgG and Alexa-Fluor-546-conjugated goat anti-rat IgG, 1:500
[4 mg/ml]; Molecular Probes).
For Figure S2B, hippocampal slices were prepared as previously described,
then fixed by PFA. Immunohistochemistry was performed on fixed tissue from
CR3 KO mice to label CD11b and Iba-1 epitopes. The tissue was incubated
with antibodies against CD11b or Iba-1 and washed before incubation with
either Alexa-594-conjugated anti-rat IgG (4 mg/ml) or Alexa-488-conjugated
anti-rabbit IgG (4 mg/ml) antibodies, respectively.
PP2A Activity Assay
PP2A Immunoprecipitation Phosphatase Assay Kits (Millipore) were used
to assess PP2A activity in slices. PP2A activity was measured by reaction
with phosphopeptide. Results were normalized by total protein level of the
samples.
Peptide Design
The blocking peptide of NADPH oxidase was designed to interfere with the
assembly of NADPH oxidase components (Rey et al., 2001). The TAT
sequence was attached to transport functional peptides through the plasma
membrane (Mann and Frankel, 1991; Schwarze et al., 2000). Peptides were
generated by Anaspec, and the sequences are as follows: TAT-Phox:
RKKRRQRRR-CSTRIRRQL; TAT-Phoxscr: RKKRRQRRR-CLRITRQSR.
The blocking peptide TAT-MyD88 mimics the BB-loop of MyD88 TIR
domains and was designed to interfere with the interaction between toll-like
receptor 4 (TLR4) and myeloid differentiation primary response gene 88
(MyD88) (Hines et al., 2013; Loiarro et al., 2005). Peptides were generated
by Anaspec, and the sequence is as follows: TAT-MyD88: YGRKKRRQRRR-
RDVLPGT.
The blocking peptides of GluA2-mediated AMPAR endocytosis were
designed to mimic the end of the GluA2 C terminus and interfere with
AMPAR endocytosis (Ahmadian et al., 2004). Peptides were generous giftsNeuron 82, 195–207, April 2, 2014 ª2014 Elsevier Inc. 205
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Microglial CR3 Triggers LTD via NADPH Oxidasefrom Dr. Yu Tian Wang’s lab. The sequences were as follows: TAT-
GluA23Y: YGRKKRRQRRR-YKEGYNVYG; GluA23Y: YKEGYNVYG; GluA2scr:
AKEGANVAG.
Data Analysis and Statistics
All values shown in the figures are the mean ± SEM with baselines or controls
set as 100%. n is the number of experiments conducted. One hippocampal
slice was used for one experiment, unless otherwise indicated. Statistical
significance was assessed using one-way ANOVA (* or #: p < 0.05; ** or ##:
p < 0.01; *** or ###: p < 0.001).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.neuron.2014.01.043.
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